FDA evaluation of antimicrobials: subgroup analysis

Chest. 2005 Jun;127(6):2298-9; authore reply 2300-1. doi: 10.1378/chest.127.6.2298.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Evaluation*
  • Drug Resistance, Bacterial
  • Humans
  • Microbial Sensitivity Tests
  • Patient Selection
  • Product Surveillance, Postmarketing / standards*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Bacterial Agents